Company NEOVACS Euronext Paris

Equities

ALNEV

FR001400HDX0

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

End-of-day quote Euronext Paris Other stock markets 06:00:00 2024-02-04 pm EST			5-day change	1st Jan Change
1.98 ^EUR	-1.00%		-1.00%	-1.00%

NEOVACS has become a major player in the therapeutic vaccines for the treatment of autoimmune and / or inflammatory diseases. With its innovative technology inducing a polyclonal immune response, protected by four patent families potentially until 2038, NEOVACS focuses its clinical efforts on the development of IFN?-Kinoid for treating lupus. The group also carries out preclinical work on other therapeutic vaccines to treat autoimmune diseases, cancer, allergies and type 1 diabetes.

EUR in Million	2021	Weight	2022	Weight	Delta
Immunotherapy 100.0 %	0	100.0 %	0	100.0 %	-95.07%

EUR in Million	2021	Weight	2022	Weight	Delta
France 100.0 %	0	100.0 %	0	100.0 %	-95.07%

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	140	0 ( 0.1248 %)	0	0.1248 %

Name	Equities	%	Valuation
Dominique Catteaux Gestion 0.000000 %	0	0.000000 %	- €
Allianz Global Investors GmbH (France) 0.000000 %	0	0.000000 %	- €
La Mondiale SAM (Investment Portfolio) 0.000000 %	0	0.000000 %	- €
Martin Maurel Gestion Institutionnelle SA 0.000000 %	0	0.000000 %	- €
Uzes Gestion SA 0.000000 %	0	0.000000 %	- €
La Financière Desselligny SA 0.000000 %	0	0.000000 %	- €
Cogéfi Gestion SA 0.000000 %	0	0.000000 %	- €

Neovacs SA

3-5, Impasse Reille

75014, Paris

http://www.neovacs.fr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	-0.02%	42.11B
LONZA GROUP AG	+48.71%	40.08B
MODERNA, INC.	+5.04%	40B
CELLTRION, INC.	-11.32%	26.87B
ICON PUBLIC LIMITED COMPANY	+5.25%	24.58B
ALNYLAM PHARMACEUTICALS, INC.	-23.83%	18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.62%	11.94B
MEDPACE HOLDINGS, INC.	+22.75%	11.66B
UNITED THERAPEUTICS CORPORATION	+6.44%	11.01B

Other Biotechnology & Medical Research